Table 2.
Adenosine | Exercise | |||
---|---|---|---|---|
Variable | Young | Older | Young | Older |
FBF (ml min−1) | ||||
Baseline | 34 ± 5 | 39 ± 6 | 35 ± 4 | 45 ± 9 |
Pre-tyramine | 152 ± 31 | 151 ± 24 | 203 ± 21 | 188 ± 21 |
Post-tyramine | 65 ± 14 | 90 ± 12 | 159 ± 16† | 135 ± 15† |
FVC (ml min−1 (100 mmHg)−1) | ||||
Baseline | 38 ± 6 | 42 ± 7 | 39 ± 4 | 48 ± 9 |
Pre-tyramine | 173 ± 35 | 161 ± 25 | 228 ± 23 | 196 ± 23 |
Post-tyramine | 72 ± 15 | 94 ± 13 | 171 ± 17† | 136 ± 16† |
MAP (mmHg) | ||||
Baseline | 90 ± 2 | 95 ± 3 | 90 ± 2 | 95 ± 3 |
Pre-tyramine | 88 ± 2 | 95 ± 3 | 89 ± 2 | 97 ± 3 |
Post-tyramine | 90 ± 2 | 97 ± 3 | 92 ± 2 | 100 ± 3* |
P = 0.05 older versus young within same hyperaemic condition;
P < 0.05 exercise versus adenosine within same age group. FBF, forearm blood flow; FVC, forearm vascular conductance; MAP, mean arterial pressure.